| scholarly article | Q13442814 |
| P356 | DOI | 10.2147/JIR.S40092 |
| P8608 | Fatcat ID | release_mfj2iyxfdffullkbpybjg3tzim |
| P932 | PMC publication ID | 3650567 |
| P698 | PubMed publication ID | 23667316 |
| P5875 | ResearchGate publication ID | 236693087 |
| P50 | author | Ingo Stricker | Q115686185 |
| P2093 | author name string | Waldemar Uhl | |
| Thomas Herdegen | |||
| Ansgar M Chromik | |||
| Christoph Hilgert | |||
| Jonas Kersting | |||
| Kirstin Reinecke | |||
| Monika S Janot | |||
| Sabine Kersting | |||
| Volker Behrendt | |||
| P2860 | cites work | Signal transduction by the JNK group of MAP kinases | Q28142592 |
| Anti-interleukin-12 antibody for active Crohn's disease | Q28292686 | ||
| Signalling pathways and molecular interactions of NOD1 and NOD2 | Q28298636 | ||
| SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase | Q28364720 | ||
| The JNK inhibitor XG-102 protects against TNBS-induced colitis | Q28481470 | ||
| NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses | Q28588300 | ||
| Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation | Q29614227 | ||
| Cytokine therapy for Crohn's disease: advances in translational research | Q30442580 | ||
| Infliximab for the treatment of fistulas in patients with Crohn's disease | Q33860666 | ||
| Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group | Q33927770 | ||
| Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death | Q33930576 | ||
| Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease | Q33956768 | ||
| Therapeutic and prophylactic thalidomide in TNBS-induced colitis: synergistic effects on TNF-alpha, IL-12 and VEGF production | Q34098863 | ||
| Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. | Q50517017 | ||
| Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. | Q53540951 | ||
| A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus | Q63343005 | ||
| Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) | Q70823350 | ||
| Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency | Q73169545 | ||
| Mice lacking transforming growth factor alpha have an increased susceptibility to dextran sulfate-induced colitis | Q73675999 | ||
| Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease | Q77921868 | ||
| p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease | Q78058025 | ||
| Genetic deletion of JNK1 and JNK2 aggravates the DSS-induced colitis in mice | Q79965155 | ||
| The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis | Q83185411 | ||
| A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss. | Q34247022 | ||
| MAP kinases in the immune response | Q34542231 | ||
| The immunology of mucosal models of inflammation | Q34542265 | ||
| Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. | Q35023644 | ||
| Update in inflammatory bowel disease pathogenesis | Q36036554 | ||
| Role of MAP kinase-dependent apoptotic pathway in innate immune responses and viral infection | Q36501681 | ||
| Critical appraisal of the current practice in murine TNBS-induced colitis | Q36609213 | ||
| Knockout of the c-Jun N-terminal Kinase 2 aggravates the development of mild chronic dextran sulfate sodium colitis independently of expression of intestinal cytokines TNFα, TGFB1, and IL-6. | Q36620448 | ||
| Role of the JNK signal transduction pathway in inflammatory bowel disease | Q37054358 | ||
| Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis | Q37098695 | ||
| Mitogen activated protein kinases: a role in inflammatory bowel disease? | Q37605958 | ||
| The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator | Q40055054 | ||
| Inhibition of RICK/nuclear factor-kappaB and p38 signaling attenuates the inflammatory response in a murine model of Crohn disease. | Q40448426 | ||
| Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease | Q40491913 | ||
| Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. | Q41418413 | ||
| Reduced susceptibility of mice overexpressing transforming growth factor alpha to dextran sodium sulphate induced colitis | Q41820837 | ||
| Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines | Q42464997 | ||
| A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. | Q42492730 | ||
| Clinicopathologic study of dextran sulfate sodium experimental murine colitis. | Q42506472 | ||
| Chemically induced mouse models of intestinal inflammation | Q42510602 | ||
| Inflammatory signal transduction in Crohn's disease and novel therapeutic approaches | Q42525644 | ||
| c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation | Q42944720 | ||
| A peptide inhibitor of c-Jun N-terminal kinase for the treatment of endotoxin-induced uveitis | Q43099140 | ||
| JNK inhibition and inflammation after cerebral ischemia | Q43244845 | ||
| Randomized, controlled trial of recombinant human interleukin-11 in patients with active Crohn's disease | Q43904258 | ||
| A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia | Q44560865 | ||
| A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice | Q44753508 | ||
| The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study | Q46206143 | ||
| Oral administration of taurolidine ameliorates chronic DSS colitis in mice | Q46922561 | ||
| A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo | Q47310567 | ||
| Involvement of CD4+ T cells in the development of dextran sulfate sodium-induced experimental colitis and suppressive effect of IgG on their action | Q47691185 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | murine model | Q122890741 |
| P304 | page(s) | 71-81 | |
| P577 | publication date | 2013-05-03 | |
| P1433 | published in | Journal of Inflammation Research | Q6295349 |
| P1476 | title | The impact of JNK inhibitor D-JNKI-1 in a murine model of chronic colitis induced by dextran sulfate sodium | |
| P478 | volume | 6 |
| Q60915735 | Anti-Inflammatory Effect of IL-37-Producing T-Cell Population in DSS-Induced Chronic Inflammatory Bowel Disease in Mice |
| Q48259906 | Impaired resolution of DSS-induced colitis in mice lacking the glucocorticoid receptor in myeloid cells. |
| Q27023869 | JNK signalling in cancer: in need of new, smarter therapeutic targets |
| Q34719329 | Molecular mechanism of protopanaxadiol saponin fraction-mediated anti-inflammatory actions |
| Q39578562 | Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction by Inhibiting Cytokine-Induced Myosin Light-Chain Kinase Expression and c-Jun N-Terminal Kinase 1/2 Activation |
| Q28543472 | Resveratrol modulates cytokine-induced Jak/STAT activation more efficiently than 5-aminosalicylic acid: an in vitro approach |
| Q51653926 | Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development. |
| Q46474665 | Role of pregnane X-receptor in regulating bacterial translocation in chronic liver diseases |
| Q93028197 | Selective inhibitors for JNK signalling: a potential targeted therapy in cancer |
| Q38399146 | Therapeutic potential of tonsil-derived mesenchymal stem cells in dextran sulfate sodium-induced experimental murine colitis |
| Q55005402 | c-Jun N-terminal kinase 2 promotes enterocyte survival and goblet cell differentiation in the inflamed intestine. |
Search more.